![]() |
市场调查报告书
商品编码
1679210
2030 年藻酸盐敷料市场预测:按产品、材料、分销管道、应用、最终用户和地区进行的全球分析Alginate Dressings Market Forecasts to 2030 - Global Analysis By Product, Material, Distribution Channel, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球藻酸盐敷料市场价值为 8.6 亿美元,预计到 2030 年将达到 12.8 亿美元,预测期内的复合年增长率为 6.2%。
海藻酸盐敷料是由天然海藻中的海藻酸製成的先进创伤护理产品。这种吸收性极强的敷料在与伤口渗出液接触时会形成凝胶状物质,有效控制引流,同时创造一个湿润的癒合环境。藻酸盐敷料可减少细菌污染,促进自溶,且易于去除,不会对伤口床造成创伤。它们通常不粘连,需要二次敷料来牢固固定。
根据美国医疗保健研究和品质机构的数据,2% 至 4% 的住院患者会出现 SSI。
慢性伤口增多
糖尿病足溃疡、压疮和静脉性腿部溃疡等慢性伤口的增加趋势是藻酸盐敷料发展的主要驱动力。全球糖尿病盛行率不断上升、肥胖症以及人口老化也进一步加剧了对有效创伤护理产品的需求。此外,医疗保健基础设施的进步和对最新伤口管理技术的日益认识正在推动藻酸盐敷料的采用,从而推动全球市场的扩张。
伤口过度干燥的风险
藻酸盐敷料可以吸收多余的渗出液并使伤口过度干燥,导致伤口床干燥和延迟癒合。对于低渗出液伤口来说,这尤其成问题,会导致组织脱水和不适。过度干燥的风险限制了它的应用,并且使其不适合某些类型的伤口。此外,患者不满意和因使用不当而导致的併发症进一步抑制了市场扩张。
创伤护理技术的进步
抗菌藻酸盐敷料、提高吸收能力以及与银或蜂蜜相结合的敷料等创新技术正在提高其在治疗慢性和急性伤口方面的有效性。生物活性和智慧敷料的应用正在增加,特别是在治疗糖尿病足部溃疡、烧烫伤和手术伤口方面的需求不断增加。此外,成本效益和环境友善的藻酸盐敷料的开发正在支持市场扩张。随着医疗保健系统优先考虑先进的伤口管理解决方案,技术进步继续推动市场全球成长。
先进敷料高成本
藻酸盐敷料价格昂贵,因为其具有来自海藻的先进创伤治疗特性以及有效处理渗出液的能力。製造成本高,包括原料、加工等,是价格高的原因之一。此外,由于预算限制,医疗机构和患者可能不愿意采用这些敷料,尤其是在低收入地区。高成本降低了可近性、降低了采用率并限制了成本敏感的医疗保健系统的需求,从而阻碍了市场成长。
COVID-19 疫情以多种方式影响了藻酸盐敷料市场。虽然供应链中断和医院就诊次数减少最初减缓了市场成长,但对 COVID-19 患者(尤其是住院时间较长的患者)创伤护理的关注度增加提振了需求。向家庭医疗保健和远端医疗的转变进一步刺激了对包括藻酸盐敷料在内的先进创伤护理产品的需求,帮助市场在疫情后保持弹性。
预计海藻酸钙敷料市场在预测期内将占最大份额
预计预测期内海藻酸钙敷料部分将占据最大的市场占有率。海藻酸钙敷料是由海藻中的海藻酸纤维製成的先进创伤护理产品。这些吸水性极强的敷料能促进湿润的癒合环境,并有助于自溶脱层。海藻酸钙敷料有助于减少出血、降低感染风险并促进更快的组织再生。这些敷料需要二次敷料才能安全放置,并且可以轻鬆移除而不会造成创伤。
预计预测期内慢性伤口部分将以最高的复合年增长率成长。
预计预测期内慢性伤口部分将出现最高的成长率。藻酸盐敷料对治疗压疮、糖尿病足溃疡和静脉性腿部溃疡等慢性伤口非常有效。该敷料由海藻中提取的藻酸盐製成,与伤口渗出液接触后会形成凝胶,保持湿润的癒合环境并促进自溶剥落。它具有很强的吸收性,非常适合用于治疗渗出液较多的伤口,降低浸渍风险。
在预测期内,由于中国、印度和日本等国家慢性伤口盛行率不断上升、人口老化加剧以及糖尿病发病率不断上升,预计亚太地区将占据最大的市场占有率。该市场的主要参与者包括KIMICA、山东洁晶集团、青岛聚大洋藻业集团等。医疗保健基础设施的改善和对先进创伤护理解决方案的认识不断提高也促进了市场的扩大。
由于糖尿病溃疡和压疮等慢性伤口的盛行率不断上升以及人口老化,预计北美将在预测期内出现最高的复合年增长率。先进的医疗保健基础设施和对创伤护理管理日益增强的认识促进了市场的成长。美国因医疗费用高昂且外科手术数量不断增加而占据主导地位。伤口敷料技术的进步以及对经济高效的治疗解决方案的需求进一步推动了其应用。
According to Stratistics MRC, the Global Alginate Dressings Market is accounted for $0.86 billion in 2024 and is expected to reach $1.28 billion by 2030 growing at a CAGR of 6.2% during the forecast period. Alginate dressings are advanced wound care products made from natural seaweed-derived alginic acid. These highly absorbent dressings form a gel-like consistency upon contact with wound exudate, creating a moist healing environment while effectively managing drainage. Alginate dressings help reduce bacterial contamination, promote autolytic debridement, and can be easily removed without causing trauma to the wound bed. They are typically non-adhesive and may require a secondary dressing for secure placement.
According to the Agency for Healthcare Research and Quality, SSIs occur in 2 to 4% of the total number of patients undergoing inpatient surgical procedures.
Rising prevalence of chronic wounds
The rising prevalence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is a key driver of the alginate dressings. The increasing global incidence of diabetes, obesity, and aging populations further contributes to the growing demand for effective wound care products. Additionally, advancements in healthcare infrastructure and heightened awareness of modern wound management techniques propel the adoption of alginate dressings, driving market expansion worldwide.
Risk of over-drying wounds
Alginate dressings can over-dry wounds by absorbing excess exudate, potentially leading to desiccation of the wound bed and delayed healing. This is particularly problematic for wounds with minimal exudate, as it can cause tissue dehydration and discomfort. The risk of over-drying limits their applicability, making them unsuitable for certain wound types. Additionally, patient dissatisfaction and complications from improper use further restrain market expansion.
Advancements in wound care technologies
Innovations such as antimicrobial alginate dressings, improved absorption capacities, and combination dressings with silver or honey boost their efficacy in managing chronic and acute wounds. The rising adoption of bioactive and smart dressings accelerates demand, particularly in treating diabetic foot ulcers, burns, and surgical wounds. Additionally, the development of cost-effective and eco-friendly alginate dressings supports market expansion. As healthcare systems prioritize advanced wound management solutions, technological progress continues to propel the market's growth globally.
High cost of advanced dressings
Alginate dressings are costly due to their advanced wound-healing properties, derived from seaweed, and their ability to manage exudate efficiently. The high production costs, including raw materials and processing, contribute to their expensive pricing. Additionally, healthcare facilities and patients may hesitate to adopt these dressings due to budget constraints, especially in low-income regions. The high cost hampers market growth by reducing accessibility, slowing adoption rates, and restricting demand in cost-sensitive healthcare systems.
The covid-19 pandemic had a mixed impact on the alginate dressings market. While disruptions in the supply chain and reduced hospital visits initially slowed market growth, the increased focus on wound care for covid-19 patients, especially those with prolonged hospital stays, boosted demand. The shift towards home healthcare and telemedicine further increased the demand for advanced wound care products, including alginate dressings, ensuring continued market resilience post-pandemic.
The calcium alginate dressings segment is expected to be the largest during the forecast period
The calcium alginate dressings segment is expected to account for the largest market share during the forecast period. Calcium alginate dressings are advanced wound care products made from seaweed-derived alginate fibers. These highly absorbent dressings promote a moist healing environment and aiding in autolytic debridement. Calcium alginate dressings help control bleeding, reduce infection risk, and support faster tissue regeneration. They require secondary dressings for secure placement and are easy to remove without causing trauma.
The chronic wounds segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the chronic wounds segment is predicted to witness the highest growth rate. Alginate dressings are highly effective for managing chronic wounds, such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers. Made from seaweed-derived alginic acid, these dressings form a gel when in contact with wound exudate, maintaining a moist healing environment and promoting autolytic debridement. Their high absorbency makes them ideal for heavily exuding wounds, reducing the risk of maceration.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increasing prevalence of chronic wounds, a growing aging population, and a rising incidence of diabetes in countries like China, India, and Japan. Key players in this market include KIMICA, Shandong Jiejing Group, and Qingdao Gather Great Ocean Algae Industry Group. Improving healthcare infrastructure and greater awareness of advanced wound care solutions further contribute to market expansion.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by the rising prevalence of chronic wounds, such as diabetic ulcers and pressure sores, along with an aging population. Advanced healthcare infrastructure and growing awareness of wound care management contribute to market growth. The U.S. dominates due to high healthcare spending and increasing surgical procedures. Technological advancements in wound dressings, along with the demand for cost-effective and efficient healing solutions, further boost adoption.
Key players in the market
Some of the key players in Alginate Dressings market include 3M, Advanced Medical Solutions Limited, B. Braun Melsungen AG, BSN medical GmbH, Cardinal Health, Coloplast A/S, Convatec Inc., Hollister Inc., Medline Industries, Inc., Molnlycke Health Care, Paul Hartmann AG, Roosin Medical Co., Ltd., Smith & Nephew Plc, Boryung Corporation and KCI Medical.
In February 2025, Boryung has introduced a new line of customized Liquidem dressings specifically designed to address various winter-related wounds. These advanced dressings aim to provide effective treatment and protection against common winter skin issues, such as dryness-induced cracks, frostbite, and other cold-related injuries. By tailoring their products to meet the unique challenges posed by colder weather, Boryung seeks to enhance wound care and promote faster healing during the winter season.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.